Online registration

TAT 2012 in Amsterdam, The Netherlands, will be the tenth meeting in the series named in full "International Congress on Targeted Anticancer Therapies". Like all TAT meetings held since 2005, TAT 2012 will be another official ESMO Partnership Meeting. TAT 2012 is  offered by the Amsterdam-based NDDO Education Foundation, and is co-sponsored by the U.S. National Cancer Institute - Center for Cancer Research.

TAT meetings are characterized by their focus on targeted cancer therapeutics, in particular the most promising ones in the late preclinical and early clinical development stages. TAT 2012 will offer excellent opportunities for the presentation and discussion of ongoing and completed phase 1 studies in a highly interactive setting. Apart from being of importance to everyone involved in anticancer drug development on a daily basis, the TAT 2012 program will also be of educational value to oncologists wishing to stay abreast of emerging new treatment options.

Distinguishing features of TAT 2012:

• Highly focused on early phase development of promising targeted agents for cancer therapy
• Medium-sized event, creating excellent possibilities for personal interactions with colleagues
• Participants from academia and industry
• No paralllel sessions, avoiding the need to make difficult choices
• Attention to methodological and regulatory issues in new drug development
• Ample opportunity to present your own work in front of an international expert audience   

Amsterdam as the venue of TAT 2012 hardly needs any further introduction. By having TAT 2012 in Amsterdam, the congress returns to its city of origin, a city well known to many who attended previous NDDO new drug meetings. RAI Elicium, the congress venue, allows very convenient travel (e.g., only 10 minutes from Amsterdam Schiphol Airport by train).

GET A GLIMPSE OF THE FUTURE OF SYSTEMIC CANCER THERAPY AT TAT 2012

For further information, please visit: http://www.tatcongress.org/tat12-home.html

Registration

January 8	Deadline early registration
January 15	Deadline registration presenting authors; necessary to ensure abstract scheduling
February 8	Deadline cancellation; reimbursement of registration fee, minus EUR 50.00 handling charges until this date
March 4	Deadline advance registration; no reduced fees as of March 5
March 8-10	On-site registration at venue open; registration hours to be announced

 

Abstracts 

January 8	Deadline abstract submission
January 15	Deadline abstract withdrawal/modification
January 15	Deadline registration presenting authors; necessary to ensure abstract scheduling
January 25	Notification of abstract scheduling/rejection to submitting author
March 7	Date of release of submitted (accepted) and invited abstracts